Clinical Trial Update: Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer

View source ↗

Summary

A clinical trial evaluating tumor response to tirapazamine in cervical cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tirapazamine (tirapazamine)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Cervix Cancer | Status: TERMINATED